# Bacillus subtilis B10

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bacillus-subtilis-b10
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Fermented/Probiotic
**Also Known As:** B. subtilis B10, Bacillus subtilis strain B10, BS-B10, Probiotic strain B10, Spore-forming probiotic B10

## Overview

Bacillus subtilis B10 is a spore-forming [probiotic](/ingredients/condition/gut-health) bacterium that produces [antimicrobial](/ingredients/condition/immune-support) compounds and enzymes to support gut health. It enhances intestinal barrier function by increasing villus height and goblet cell production while modulating beneficial bacterial populations.

## Health Benefits

• Modulates gut microbiota composition by increasing beneficial bacteria like Streptococcus and altering Firmicutes/Bacteroidetes ratios (animal studies only)
• Enhances intestinal barrier function through improved villus height/width and increased goblet cells (demonstrated in broiler studies)
• Supports metabolic health by reducing weight gain, serum glucose, and hepatic triglycerides (shown in high-fat diet mouse models)
• Improves nutrient [digestion](/ingredients/condition/gut-health) through production of exoenzymes targeting proteins, lipids, and polysaccharides (mechanistic evidence from animal studies)
• Demonstrates pathogen exclusion potential through biofilm formation and adherence to intestinal matrix proteins (in vitro evidence)

## Mechanism of Action

Bacillus subtilis B10 produces [antimicrobial](/ingredients/condition/immune-support) peptides like surfactin and iturin that inhibit pathogenic bacteria while promoting beneficial Streptococcus species. The strain enhances [intestinal barrier integrity](/ingredients/condition/gut-health) by stimulating goblet cell proliferation and mucin secretion. It modulates immune responses through toll-like receptor pathways and produces enzymes that aid nutrient digestion.

## Clinical Summary

Current evidence for Bacillus subtilis B10 comes primarily from animal studies, particularly broiler chicken research. Studies have demonstrated improved villus height-to-width ratios and increased goblet cell density in intestinal tissue. Research shows modulation of gut microbiota with increased Firmicutes/Bacteroidetes ratios and enhanced Streptococcus populations. Human clinical trials specifically testing the B10 strain are currently limited, requiring more research to confirm benefits in humans.

## Nutritional Profile

Bacillus subtilis B10 is a probiotic microorganism, not a conventional food ingredient, and thus does not contribute meaningful macronutrients or micronutrients in the quantities administered. Key bioactive contributions include: (1) Enzymatic secretions — B. subtilis strains are well-documented producers of proteases (subtilisin, neutral protease), amylases, lipases, and phytases, which enhance host digestion and nutrient bioavailability of feed/food components, particularly phosphorus liberation from phytate (phytase activity can increase phosphorus bioavailability by 20–40% in animal studies); (2) [Antimicrobial](/ingredients/condition/immune-support) peptides (bacteriocins) — produces lipopeptides including iturin A, surfactin, and fengycin, which contribute to competitive exclusion of pathogens rather than direct host nutrition; (3) Short-chain fatty acid (SCFA) stimulation — indirectly promotes butyrate, acetate, and propionate production in the colon through microbiota modulation, with butyrate concentrations in cecal contents reported to increase by approximately 15–30% in broiler studies; (4) Vitamin synthesis potential — B. subtilis species are known producers of riboflavin (vitamin B2) and menaquinone (vitamin K2, specifically MK-7), though strain-specific yield data for B10 designation is not independently published; (5) Protein/cell mass contribution — as a bacterial cell, B. subtilis contains approximately 50–60% protein (dry cell weight), ~15% nucleic acids, ~10% lipids, and ~10–15% carbohydrates (cell wall polysaccharides including teichoic acids), but these are present in negligible quantities at typical probiotic dosing levels (10^8–10^9 CFU/g); (6) Bioavailability note — the primary nutritional impact is indirect, mediated through enzymatic activity and [microbiome](/ingredients/condition/gut-health) modulation rather than direct nutrient delivery; spore-forming capacity of B. subtilis confers stability through processing and gastric transit, with spore survival rates reported above 85% after simulated gastric acid exposure (pH 2.0, 2 hours) in related B. subtilis strains.

## Dosage & Preparation

Animal studies utilized 1 × 10^8 CFU/kg of feed for broilers over 72 days. No human dosages have been established for B10 specifically. General B. subtilis [probiotic](/ingredients/condition/gut-health)s typically use spore forms at 10^8-10^9 CFU/day, but this is not B10-specific. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bacillus subtilis B10 appears generally safe as a spore-forming [probiotic](/ingredients/condition/gut-health) with low risk of translocation due to its transient gut colonization. Potential side effects may include mild digestive upset during initial supplementation. No specific drug interactions have been reported, though antibiotic use may reduce effectiveness. Safety during pregnancy and lactation has not been established through human studies.

## Scientific Research

Current evidence for Bacillus subtilis B10 is limited to animal studies, with no human clinical trials, RCTs, or meta-analyses identified. Key studies include a 72-day broiler feeding trial showing microbiota modulation and growth improvements at 1 × 10^8 CFU/kg feed, and mouse studies demonstrating metabolic benefits in high-fat diet-induced obesity models.

## Historical & Cultural Context

No historical or traditional medicine use was identified for Bacillus subtilis B10 specifically, as it appears to be a modern research isolate. While general B. subtilis strains are found in fermented foods like nattō, the B10 strain has no documented traditional use.

## Synergistic Combinations

Other Bacillus strains, Lactobacillus species, prebiotic fibers, [digestive enzyme](/ingredients/condition/gut-health)s, glutamine

## Frequently Asked Questions

### What makes Bacillus subtilis B10 different from other probiotics?

Bacillus subtilis B10 forms protective spores that survive stomach acid and heat, unlike vegetative probiotics like Lactobacillus. It produces unique antimicrobial compounds including surfactin and iturin peptides that specifically target pathogenic bacteria.

### How long does Bacillus subtilis B10 stay in the gut?

Bacillus subtilis B10 provides transient colonization, typically remaining active for 7-14 days after supplementation stops. Unlike permanent gut residents, it functions as a passing beneficial organism that modulates the existing microbiome during transit.

### What dosage of Bacillus subtilis B10 is effective?

Animal studies have used doses ranging from 10^6 to 10^9 CFU per day with positive results. Human dosing protocols are not well-established, as most commercial products contain 10^8-10^9 CFU per serving.

### Can Bacillus subtilis B10 survive antibiotic treatment?

The spore form of Bacillus subtilis B10 shows some resistance to certain antibiotics, but effectiveness is generally reduced during antibiotic therapy. Supplementation is often recommended after completing antibiotic courses to restore beneficial bacteria.

### Does Bacillus subtilis B10 help with specific digestive conditions?

Research shows Bacillus subtilis B10 may benefit intestinal barrier dysfunction and dysbiosis-related conditions. However, most evidence comes from animal models, with limited human clinical data for specific digestive disorders like IBS or IBD.

### What does clinical research show about Bacillus subtilis B10's effects on metabolic health?

Animal studies have demonstrated that Bacillus subtilis B10 can reduce weight gain, lower serum glucose levels, and decrease hepatic triglycerides, suggesting potential metabolic benefits. However, these findings are primarily from broiler and rodent models, and human clinical trials are needed to confirm whether these metabolic effects translate to supplementation in people. The mechanism appears to involve microbiota modulation that favorably influences glucose and lipid metabolism.

### Is Bacillus subtilis B10 safe for children and the elderly?

Bacillus subtilis B10 is generally recognized as safe for use in poultry and animal models across different ages, but specific safety data in human pediatric and geriatric populations remains limited. The spore-forming nature of this strain makes it more stable than many conventional probiotics, potentially beneficial for vulnerable populations who need shelf-stable options. However, elderly individuals and children should consult a healthcare provider before starting supplementation, particularly those with compromised immunity or serious underlying conditions.

### How does Bacillus subtilis B10 strengthen the intestinal barrier?

Research in broiler studies shows that Bacillus subtilis B10 enhances intestinal barrier function by increasing villus height and width, which expands the surface area for nutrient absorption, and by promoting goblet cell production, which increases protective mucus secretion. These structural improvements create a more robust intestinal epithelium that better resists pathogenic colonization and bacterial translocation. While these mechanisms have been clearly demonstrated in animal models, human studies examining intestinal morphology changes are needed to confirm these benefits in supplement users.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*